Skip to content

A Clinical Study of Epilepsy Localization and Prognosis Based on PET and Resting-state fMRI

A Clinical Study of Epilepsy Localization and Prognosis Based on Positron Emission Tomography and Resting-state Functional Magnetic Resonance Imaging

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05567042
Enrollment
50
Registered
2022-10-05
Start date
2022-10-31
Completion date
2024-07-31
Last updated
2022-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epileptic Seizure

Brief summary

1. By following up the prognosis of surgical patients, the application value of Cortex ID quantitative analysis in the localization of epilepsy foci was studied. 2. By studying the correlation between autonomic nerve function and epilepsy neural network in epilepsy patients, and analyzing the differences between different epilepsy patients, it can provide more information for judging the prognosis of epilepsy patients.

Detailed description

This study included diagnostic trials and case-control studies, which were observational studies with no intervention. First, the demographic and clinical information of epilepsy patients in the Neurology Department of Xijing Hospital were collected, including gender, age, age of onset, course of epilepsy, seizure performance before treatment, seizure frequency before treatment, type and dose of antiepileptic drugs, past history, Family history, etc., as well as imaging, EEG, quality of life, and neuropsychological assessment, etc. were collected; secondly, functional magnetic resonance imaging (fMRI) and 24-hour Holter monitoring were performed on patients who met the inclusion criteria. Positron Emission Computed Tomography (PET) images of patients who have undergone or plan to undergo surgery are analyzed; finally, appropriate statistical methods are used for analysis.

Interventions

OTHERNo intervention

No intervention

Sponsors

Li Shuangshuang
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

Meet the diagnostic criteria for epilepsy, * No contraindications for fMRI examination. * The patient had no other heart and lung diseases except epilepsy. * Patients and their families were aware of this study and signed informed consent.

Exclusion criteria

* Patients with severe infection, cerebrovascular disease, malignant tumor and other systemic diseases that can affect the nervous system, and those with serious dysfunction of the heart, liver, kidney and other organs. * Non-epileptic seizures such as syncope and hysteria. * Pregnant or lactating women. Incomplete clinical data

Design outcomes

Primary

MeasureTime frame
Seizure frequency2022-2024
Seizure duration2022-2024

Contacts

Primary ContactLei Ma, doctor
shuangshuang9904@163.com13325437929
Backup ContactShuangshuang Li, doctor
shuangshuang9904@163.com13325437929

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026